Bone Marrow Edema and Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia

<b>Background and Clinical Significance</b><b>:</b> Tyrosine kinase inhibitors (TKIs) have transformed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) into a largely manageable chronic disease. However, off-target toxicities are increasingly recognized; rarer complications such a...

全面介绍

书目详细资料

Principais autores:	Sabina Russo, Manlio Fazio, Giuseppe Mirabile, Raffaele Sciaccotta, Fabio Stagno, Alessandro Allegra
格式:	Artigo
语言:	Inglês
出版:	MDPI AG 2025-12-01
丛编:	Diagnostics
主题:	bone marrow edema chronic myeloid leukemia tyrosine kinase inhibitors bosutinib CML toxicities CML therapy
在线阅读:	https://www.mdpi.com/2075-4418/15/24/3112
标签:	添加标签 没有标签, 成为第一个标记此记录!